The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes
Modern Pathology2016Vol. 29(9), pp. 1058–1069
Citations Over TimeTop 10% of 2016 papers
Olca Baştürk, Marcus Tan, Umesh Bhanot, Peter J. Allen, Volkan Adsay, Sasinya N. Scott, Ronak Shah, Michael F. Berger, Gokce Askan, Esra Dikoglu, Vaidehi Jobanputra, Kazimierz O. Wrzeszczyński, Carlie Sigel, Christine A. Iacobuzio–Donahue, David S. Klimstra
Related Papers
- → Notch and Kras in pancreatic cancer: At the crossroads of mutation, differentiation and signaling(2009)75 cited
- → Mucinous cystic neoplasms of the liver and pancreas: relationship between KRAS driver mutations and disease progression(2017)38 cited
- → Pathobiology of Precursors to Pancreatic Cancer(2021)1 cited
- → ID: 3522273 ASSESSING KRAS/GNAS AND BIOLOGIC BEHAVIOR USING MOLECULAR DNA ANALYSIS IN CHARACTERIZING PRE-MALIGNANT PANCREATIC CYSTS(2021)
- → Kras loss of heterozygosity promotes MAPK dependent pancreatic ductal adenocarcinoma and induces therapeutic sensitivity(2023)